Rare diseases
Investigational molecules
Locations
Back to Romania322 clinical trials in Timisoara, Romania across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
RomaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
RomaniaStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
RomaniaStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
RomaniaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
RomaniaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
RomaniaStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
RomaniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
RomaniaPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
RomaniaEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
RomaniaPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on pulmonary conditions including investigations of new treatments for idiopathic pulmonary fibrosis and uncontrolled asthma. Research includes evaluation of novel antibody therapies and assessment of respiratory function markers.
Comprehensive research into various cancer types, with particular emphasis on lung cancer and breast cancer treatments. Studies evaluate novel combination therapies and targeted treatments for specific genetic mutations.
Clinical investigations targeting inflammatory diseases including studies on ulcerative colitis, Crohn's disease, and Sjögren's disease. Research focuses on evaluating long-term safety and efficacy of innovative biological therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
